CAS 29115-34-2

ethyl 3-(bromomethyl)-1-benzofuran-2-carboxylate

Description:

Ethyl 3-(bromomethyl)-1-benzofuran-2-carboxylate, identified by its CAS number 29115-34-2, is an organic compound characterized by its benzofuran structure, which includes a carboxylate ester functional group and a bromomethyl substituent. This compound typically appears as a colorless to pale yellow liquid or solid, depending on its purity and form. It is soluble in organic solvents such as ethanol and dichloromethane but has limited solubility in water due to its hydrophobic benzofuran core. The presence of the bromomethyl group makes it a potential candidate for further chemical reactions, such as nucleophilic substitution, which can be exploited in synthetic organic chemistry. Ethyl 3-(bromomethyl)-1-benzofuran-2-carboxylate may exhibit biological activity, making it of interest in medicinal chemistry and drug development. However, handling this compound requires caution due to the presence of bromine, which can pose health risks. Proper safety protocols should be followed when working with this substance in a laboratory setting.

Formula: C₁₂H₁₁BrO₃

InChI: InChI=1/C12H11BrO3/c1-2-15-12(14)11-9(7-13)8-5-3-4-6-10(8)16-11/h3-6H,2,7H2,1H3

SMILES: CCOC(=O)c1c(CBr)c2ccccc2o1

Synonyms:

• 2-Benzofurancarboxylic Acid, 3-(Bromomethyl)-, Ethyl Ester
• 3-Bromomethyl-benzofuran-2-carboxylic acid ethyl ester

Ethyl 3-(bromomethyl)benzofuran-2-carboxylate

CAS: 29115-34-2

Formula: C₁₂H₁₁BrO₃

Molecular weight: 283.1179

Ref: IN-DA002XCZ

Ethyl 3-(bromomethyl)-1-benzofuran-2-carboxylate

CAS: 29115-34-2

Ethyl 3-(bromomethyl)-1-benzofuran-2-carboxylate (BMC) is a potent anticancer agent that inhibits cancer cell growth by inhibiting the activity of regulatory proteins. BMC selectively interacts with the regulatory domain of these proteins, which causes them to become inactive and inhibits tumor growth. BMC also induces necroptosis, which is an alternative form of programmed cell death that can be induced by multiple stimuli. This process results in the release of proinflammatory cytokines such as IL-1β and IL-18, which may contribute to its anti-cancer effects. BMC has been shown to inhibit murine lung tumor growth in vivo and inhibit tumor growth in vitro.

Formula: C₁₂H₁₁BrO₃

Purity: Min. 95%

Molecular weight: 283.12 g/mol

Ref: 3D-EBA11534

MCC1019

CAS: 29115-34-2

MCC1019 is a novel selective inhibitor of the Polo-box domain of Polo-like kinase 1 (PLK1).

Formula: C₁₂H₁₁BrO₃

Color and Shape: Solid

Molecular weight: 283.12

Ref: TM-T69496